Exploring Nanocarriers in Breast Cancer Management comprehensively delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast cancer. The scope of this book encompasses a thorough exploration of various nanocarrier systems, including, amongst others, liposomes, niosomes, and microneedles. It highlights recent advancements in these systems and their promising results in breast cancer treatment. Additionally, the book addresses the crucial aspects of toxicity and regulatory considerations associated with nanocarriers. It aims to provide a foundational understanding of nanocarriers, their unique features, and their significant role in breast cancer management.
As breast cancer remains one of the most prevalent forms of cancer today, with no definitive cure currently available, this book is an essential resource for researchers, healthcare professionals, and anyone interested in cutting-edge developments in breast cancer treatment.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Fundamentals and recent advances in breast cancer treatment2. Microneedles: An emerging approach for management of breast cancer
3. Niosomes: Nonionic surfactant-based system in breast cancer
4. Solid lipid nanoparticles in improving the therapeutic effectiveness of anticancer compound
5. Nanostructured lipid carrier: Second-generation nanoparticles in breast cancer managemen
6. Innovative way of treating breast cancer using carbon nanomaterials
7. Gold nanoparticles: Promising metallic nanoparticles for effective breast cancer
8. Revolutionizing breast cancer therapy with silver nanoparticles: Mechanisms and applications
9. Exploring the potential of liposomes in breast cancer therapeutics
10. Exosome-based therapy for breast cancer treatment
11. Enhanced drug delivery in breast cancer: The role of polymeric micelles
12. Dendrimer-based approaches in breast cancer management
13. Cutting-edge approaches in breast cancer treatment: The role of quantum dots/mesoporous silica nanoparticles
14. Recent advancements in breast cancer therapy
Authors
Amarjitsing Rajput University of Pune, India.Dr. Amarjitsing Rajput is currently working as an Assistant Professor in the Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth, Deemed to be University, Pune, Maharashtra, India. He received his Ph. D. from Department of Pharmaceutics Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat in 2021. He completed his M. Pharmacy in Pharmaceutics from North Maharashtra University, Jalgaon, Maharashtra. During his doctoral research, he worked on nanostructured lipid carriers and liposomes to manage Alzheimer's disease. He continued his Postdoctoral Research at the Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai, India. His area of research includes nanocarriers, microneedle technology, brain targeting, and transdermal drug delivery to manage skin diseases. To his credit, he has more than 35 publications in numerous National and International journals of repute and 15 book chapters. Moreover, he reviews many esteemed international journals,
Satish Mandlik Department of Pharmaceutics, Poona College of Pharmacy Bharti Vidyapeeth Deemed University Pune, Maharashtra, India.Dr Mandlik holds the following degrees: M. Pharm, Ph.D (Pharmacology). Dr Mandlik has been a researcher and lecturer for over 10 years. Dr Mandlik's research interests include: hepatoprotection; inflammation and immunity; gene transactivation and transrepression; anti-diabetic studies; and toxicity studies
Praveen Subbappa Azurity Pharmaceuticals, USA. Mr. Praveen Subbappa is a seasoned pharmaceutical executive with over 25 years of experience in the industry. Currently, he serves as the Associate Vice President of Alliance Management at Azurity Pharmaceuticals in the USA. Praveen holds a postgraduate degree in Pharmaceutics from the Government College of Pharmacy, Bengaluru. Throughout his distinguished career, Praveen has held pivotal roles in renowned pharmaceutical companies such as Dr. Reddy's Laboratories Inc, Slayback Pharma LLC, and Bharat Serums & Vaccines, where he has led critical functions such as Research & Development, Technology Transfer, and Regulatory Affairs Sudarshan Singh Chiang Mai University, Thailand.Dr. Sudarshan Singh is a Frontier Proactive Research scholar at the Faculty of Pharmacy, Chiang Mai University, Thailand. He holds five patents, is approved as a PhD guide by Pacific University, Rajasthan, and is a life member of bodies including the Society of Pharmacovigilance India. He has received research and travel grants from the governments of Gujarat, ICMR, and other institutions.
His current research focuses on 3D-printed implantable green composites with polymeric biomaterials to address dermal inflammation, alongside multifunctional biomaterial development for drug delivery. Previous work involved lipid vesicular curcuminoid analogues as biodegradable scaffolds for intracellular uptake and anti-inflammatory response studies. His postdoctoral work at Prince of Songkhla University centered on biodegradable antibacterial nanoparticle wound dressings tested across multiple cell lines.
Dr. Singh is proficient in a wide range of analytical techniques, including SEM-EDX, NMR, XRD, HPLC, LC-MS, confocal microscopy, and flow cytometry.
